Market Overview

Ponzi Scheme Led By An NFL Player? Allegations Reveal Sport's 'Unique Animal'

Ponzi Scheme Led By An NFL Player? Allegations Reveal Sport's 'Unique Animal'

Former NFL cornerback WIll Allen last week was accused of setting up a Ponzi scheme. The Securities and Exchange Commission has alleged that Allen duped athletes to the tune of about $32 million.

"According to the SEC, the scheme was in effect from July 2012 to February of this year," the Washington Post noted. "Allen and a partner, Susan Daub, ran a company called Capital Financial Advisers, which took in $31.7 million from investors but paid out only $18 million in loans to professional athletes from the four major U.S. sports."

Allen played for three teams from 2001-2013, most notably the New York Giants. He had 525 tackles and 15 interceptions in his career. His NFL career earnings totaled $26.11 million.

Related Link: Tiger Woods: I Popped My Joint Back In Place On Hole No. 9 At The Masters

"Sports lending is a unique animal and it is important to keep accurate books to account for off-season periods where it is likely that a player won’t be making principal or interest payments," Leon McKenzie, owner of Sure Sports Lending, told Benzinga.

"Athletes borrowing needs cover the full spectrum of needs of those common for 18-30 year olds along with the needs of the wealthy," McKenzie said. "Unfortunately, some players are 'going broke,' but they rarely qualify for the loans done here at Sure Sports Lending."

McKenzie said his company views loans as contract advances, which typically fill the off-season cash void for items such as:

  • Training & living expenses
  • Home renovations
  • Home purchases
  • Auto purchases
  • Business ventures

McKenzie said this "is the first time I have heard of a former athlete being investigated for creating or participating in a Ponzi scheme."

Posted-In: Leon McKenzie nfl Sure Sports Lending Will AllenLegal Exclusives Best of Benzinga


Related Articles

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

FDA Advisory Committee Recommends Approval of The Medicines Company's Antiplatelet Therapy Cangrelor

Phase II Data for Apremilast in Behçet's Disease Published in The New England Journal of Medicine